Ferring licenses US rights to INVO's INVOcell fertility device; Deal to be Terminated
Executive Summary
Ferring Pharmaceuticals Inc. licensed exclusive US commercialization rights to INVO Bioscience Inc.'s INVOcell intravaginal culture (IVC) system.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice